The objective of this study was therefore to investigate the controversial role of IDO1 and IL4I1 in the largest cohort so far of HNSCC to lay the foundation for a potential use of a combined therapeutic approach in the future. This evidence concerns the gene IL4I1 and head and neck squamous cell carcinoma.